School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Tiziana Life Sciences Ltd TLSA

Healthcare · Biotechnology

$1.19last close 2026-10-09 · market cap $151.44M · delayed data

Trailing returns

1M+21.43%
3M-5.56%
6M-5.56%
1Y-44.13%
5Y-15.00%

Basis: Adjusted daily closes.

What it does

Tiziana Life Sciences Ltd, together with its subsidiaries, engages in the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally.

Open TLSA in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies